Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo
Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo
复制标题
新型紫杉烷Lx2-32c及其体内外抗肿瘤活性
DOI:
10.1016/j.canlet.2008.03.051
复制
发表时间:
2008-09-08
期刊:
影响因子:
9.7
通讯作者:
Chen, Xiaoguang
中科院分区:
文献类型:
--
作者:
Wang, Hongbo;Li, Hongyan;Chen, Xiaoguang
Lx2-32c, a novel taxane derivative, is a semisynthetic analogue from cephalomannine. Its antitumor activity in vivo and in vitro was investigated in this study. Lx2-32c was cytotoxic (IC50 = 1.7 +/- 1.6 nM) to various human tumor cell lines after 72 h incubation. In vitro it enhanced the rate of tubulin polymerization in a dose-dependent manner and induced the bundling of microtubule in BGC-823 cells with the mode similar to that of paclitaxel. As determined by flow cytometry, after either 12 or 24 h exposure, Lx2-32c caused BGC-823 cells G(2)/M phase arrest in a time- and dose-dependent manner. Moreover, we demonstrated that Lx2-32c had significant antitumor activity on BGC-823 (human gastric carcinoma) and A549 (human non-small cell lung carcinoma) xenograft in nude mice. These data suggest that Lx2-32c is a microtubule-stabilizing agent, which has significant antitumor activity in vitro and in vivo. (C) 2008 Elsevier Ireland Ltd. All rights reserved.